IDEAYA BIOSCIENCES ANNOUNCES IND SUBMISSION FOR IDE574, A POTENTIAL FIRST-IN-CLASS KAT6/7 DUAL INHIBITOR FOR BREAST AND LUNG CANCERS

Reuters · 2d ago

Please log in to view news